Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|April 22, 2010
[Comparative ultrasound visualization of clinically relevant structures for evaluating the infant hip joint utilizing trapezoidal vs. parallel transducers]R Wunsch, A Wegener-Panzer, T Reinehr, et al.
Neuropediatrics|June 5, 2019
N-Methyl-D-Aspartate Receptor Encephalitis with Psychiatric Symptoms and an Ovarian Teratoma Detected by MRI in a 17-Year-Old GirlA Barth, I Nassenstein, R B Tröbs, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1991
Infectious imaging with indium-111-labeled nonspecific polyclonal human immunoglobulinW A Wegener, M G Velchik, D Weiss, et al.
Clinical Neuroradiology|October 12, 2012
Heroin spongiform leukoencephalopathy (HSLE)A G Bach, B Jordan, N A Wegener, et al.
The Journal of Biological Chemistry|September 15, 2005
Structural analysis of a HAMP domain: the linker region of the phototransducer in complex with sensory rhodopsin IIEnrica Bordignon, Johann P Klare, Meike Doebber, et al.
Ophthalmic Research|October 5, 2001
Light scattering in normal and cataractous lenses of farmed Atlantic salmon (Salmo salar): a slit lamp and Scheimpflug photographic studyA Wegener, H Laser, M H Ahrend, et al.
The British Journal of Ophthalmology|November 22, 2005
Lower limits of fluorescein and indocyanine green dye for digital cSLO fluorescence angiographyA Bindewald, O Stuhrmann, F Roth, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2001
Primary reactions of sensory rhodopsinsI Lutz, A Sieg, A A Wegener, et al.
Cancer|October 15, 2008
Durable complete responses from therapy with combined epratuzumab and rituximab: final results from an international multicenter, phase 2 study in recurrent, indolent, non-Hodgkin lymphomaJohn P Leonard, Stephen J Schuster, Christos Emmanouilides, et al.
Arthritis Research & Therapy|July 25, 2006
Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II studySerge D Steinfeld, Laure Tant, Gerd R Burmester, et al.
Pageof 14